is compounded semaglutide going away for Women 🚨 FDA Moves to Permanently

While early Phase 2 data show a promising efficacy profile, the full side effect picture is still emerging

Patients with documented insulin resistance who also meet criteria for type 2 diabetes or obesity represent the most appropriate candidates

By working with healthcare providers, implementing strong lifestyle habits, and having realistic expectations, you can navigate this transition more successfully

Because the changes that occur on Retatrutide go well beyond what a scale captures

An exclusive in-app community where you can get support for your journey, and an expert-designed behavior change program to help you make lasting changes

doi:10.1523/JNEUROSCI.22-23-10470.2002